Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,880.00",
    "chg": 16.85,
    "chgp": "0.9%",
    "dir": 1,
    "prev_price": "1,863.15",
    "mcapval": "450,667.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "May 15",
    "curr_time": "",
    "bse_nse_vol": "28.15 lacs",
    "exc_status": "Active",
    "traded_date": "May 15, 2026",
    "traded_date_str": "2026 05 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1887.1",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs18871-3992682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_priceRelatedfactors_3992682.png",
        "date": "2026-05-15 10:36:55",
        "description": "With a decisive surge to Rs 1887.1 on 15 Jun 2026, Sun Pharmaceutical Industries Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces the broader market’s modest gains."
      },
      {
        "title": "P/E at 36.81 vs Industry's 35.33: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-nifty-50-constituent-amid-robust-institutional-interest-3992203",
        "imagepath": "",
        "date": "2026-05-15 09:21:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being a constituent of the Nifty 50 index confers considerable advantages on Sun Pharmaceutical Industries Ltd, not least in terms of visibility and liquidity. The Nifty 50, as India’s premier benchmark index, attracts substantial passive and active fund flows, with index-tracking funds and ETFs required to hold shares in proportion to their index weightings. This membership not only enhances the company’s profile among domestic and global investors but also ensures a steady demand for its shares, contributing to price stability and reduced volatility.</p>\n                <p>Sun Pharma’s current market capitalisation stands at a robust ₹4,46,996 crore, firmly placing it in the large-cap category. This scale is..."
      },
      {
        "title": "P/E at 36.05 vs Industry's 34.84: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-nifty-50-heavyweight-amid-institutional-confidence-3990700",
        "imagepath": "",
        "date": "2026-05-14 09:21:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Industry Norms</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.05, slightly above the Pharmaceuticals &amp; Biotechnology industry average of 34.84. This premium, though not excessive, suggests that the market attributes a somewhat higher growth or quality expectation to the stock compared to its peers. Given the sector’s typical valuation range, this premium is consistent with the company’s large-cap status and its historical performance track record. The market cap of ₹4,37,735 crore further cements its position as a heavyweight within the sector.</p>\n                <p>However, the premium also in..."
      },
      {
        "title": "P/E at 36.49 vs Industry's 33.86: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-amidst-nifty-50-constituency-3988998",
        "imagepath": "",
        "date": "2026-05-13 09:21:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index is a hallmark of market leadership and liquidity, and Sun Pharmaceutical Industries Ltd’s inclusion underscores its stature among India’s blue-chip companies. The Nifty 50 serves as a barometer for the Indian equity market, and constituents like Sun Pharma attract significant institutional interest, including mutual funds, insurance companies, and foreign portfolio investors. This membership not only enhances the stock’s visibility but also ensures steady demand from index-tracking funds, which can provide a stabilising effect on price volatility.</p>\n\n                <p>Sun Pharma’s market capitalisation currently stands at a robust ₹4,43,649.03 crores, firmly placing it in th..."
      },
      {
        "title": "When is the next results date for Sun Pharmaceutical Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sun-pharmaceutical-industries-ltd-3988214",
        "imagepath": "",
        "date": "2026-05-12 23:17:31",
        "description": "The next results date for Sun Pharmaceutical Industries Ltd is scheduled for 22 May 2026...."
      },
      {
        "title": "Sun Pharmaceutical Sees Significant Open Interest Surge Signalling Market Positioning Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-significant-open-interest-surge-signalling-market-positioning-shift-3987598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_oi_spurts_by_underlying_3987598.png",
        "date": "2026-05-12 12:00:15",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market positioning and potential directional bets. Despite a marginal decline in the stock price, the increase in open interest and trading volumes suggests heightened investor interest and evolving sentiment in the pharmaceuticals sector."
      },
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amidst Strong Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amidst-strong-market-positioning-3987543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_oi_spurts_by_underlying_3987543.png",
        "date": "2026-05-12 11:00:13",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market positioning and potential directional bets by investors. The increase of over 10% in open interest, coupled with steady volume and price action near its 52-week high, suggests growing investor conviction in the pharmaceutical giant’s near-term prospects."
      },
      {
        "title": "Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-ahead-of-may-expiry-3987190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_most_active_stocks_calls_3987190.png",
        "date": "2026-05-12 10:00:14",
        "description": "4,070 call contracts at the Rs 1,900 strike traded on 12 May 2026 for Sun Pharmaceutical Industries Ltd, with the stock closing just below at Rs 1,873.80. This near-the-money activity coincides with the stock trading close to its 52-week high, signalling a focused directional bet in the options market that aligns closely with the underlying price action."
      },
      {
        "title": "P/E at 37.0 vs Industry's 34.43: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strong-buy-momentum-amid-nifty-50-membership-and-institutional-confidence-3987010",
        "imagepath": "",
        "date": "2026-05-12 09:21:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a prominent member of the Nifty 50 index, Sun Pharmaceutical Industries Ltd holds a strategic position within India’s benchmark equity gauge. Inclusion in this elite group not only enhances the stock’s visibility among domestic and global investors but also ensures consistent demand from index-tracking funds and institutional portfolios. This membership acts as a catalyst for liquidity and price stability, particularly during periods of market volatility.</p>\n                <p>The company’s large-cap status, with a market capitalisation of ₹4,49,251 crores, further cements its role as a cornerstone of the Pharmaceuticals & Biotechnology sector. Its weighting within the Nifty 50 reflects both its market val..."
      }
    ],
    "total": 1106,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-May-2026",
      "details": "Earnings call for the financial results of the fourth quarter on 22 May 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "12-May-2026",
      "details": "Change in Board of Directors and Composition of Committees",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31 March 2026 And Recommendation Of Final Dividend For FY 2025-26",
      "datetime": "11-May-2026",
      "details": "Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2026 and recommendation of final dividend for FY 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "22 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1887.1

2026-05-15 10:36:55

With a decisive surge to Rs 1887.1 on 15 Jun 2026, Sun Pharmaceutical Industries Ltd has reached a fresh 52-week high, propelled by a confluence of bullish technical indicators and sustained price momentum that outpaces the broader market’s modest gains.

Read full news article

P/E at 36.81 vs Industry's 35.33: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-15 09:21:02

Significance of Nifty 50 Membership

Being a constituent of the Nifty 50 index confers considerable advantages on Sun Pharmaceutical Industries Ltd, not least in terms of visibility and liquidity. The Nifty 50, as India’s premier benchmark index, attracts substantial passive and active fund flows, with index-tracking funds and ETFs required to hold shares in proportion to their index weightings. This membership not only enhances the company’s profile among domestic and global investors but also ensures a steady demand for its shares, contributing to price stability and reduced volatility.

Sun Pharma’s current market capitalisation stands at a robust ₹4,46,996 crore, firmly placing it in the large-cap category. This scale is...

Read full news article

P/E at 36.05 vs Industry's 34.84: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-14 09:21:09

Valuation Picture: Premium Amidst Industry Norms

The current P/E of Sun Pharmaceutical Industries Ltd stands at 36.05, slightly above the Pharmaceuticals & Biotechnology industry average of 34.84. This premium, though not excessive, suggests that the market attributes a somewhat higher growth or quality expectation to the stock compared to its peers. Given the sector’s typical valuation range, this premium is consistent with the company’s large-cap status and its historical performance track record. The market cap of ₹4,37,735 crore further cements its position as a heavyweight within the sector.

However, the premium also in...

Read full news article

P/E at 36.49 vs Industry's 33.86: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-13 09:21:16

Significance of Nifty 50 Membership

Being part of the Nifty 50 index is a hallmark of market leadership and liquidity, and Sun Pharmaceutical Industries Ltd’s inclusion underscores its stature among India’s blue-chip companies. The Nifty 50 serves as a barometer for the Indian equity market, and constituents like Sun Pharma attract significant institutional interest, including mutual funds, insurance companies, and foreign portfolio investors. This membership not only enhances the stock’s visibility but also ensures steady demand from index-tracking funds, which can provide a stabilising effect on price volatility.

Sun Pharma’s market capitalisation currently stands at a robust ₹4,43,649.03 crores, firmly placing it in th...

Read full news article

When is the next results date for Sun Pharmaceutical Industries Ltd?

2026-05-12 23:17:31

The next results date for Sun Pharmaceutical Industries Ltd is scheduled for 22 May 2026....

Read full news article

Sun Pharmaceutical Sees Significant Open Interest Surge Signalling Market Positioning Shift

2026-05-12 12:00:15

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market positioning and potential directional bets. Despite a marginal decline in the stock price, the increase in open interest and trading volumes suggests heightened investor interest and evolving sentiment in the pharmaceuticals sector.

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amidst Strong Market Positioning

2026-05-12 11:00:13

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market positioning and potential directional bets by investors. The increase of over 10% in open interest, coupled with steady volume and price action near its 52-week high, suggests growing investor conviction in the pharmaceutical giant’s near-term prospects.

Read full news article

Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You

2026-05-12 10:00:14

4,070 call contracts at the Rs 1,900 strike traded on 12 May 2026 for Sun Pharmaceutical Industries Ltd, with the stock closing just below at Rs 1,873.80. This near-the-money activity coincides with the stock trading close to its 52-week high, signalling a focused directional bet in the options market that aligns closely with the underlying price action.

Read full news article

P/E at 37.0 vs Industry's 34.43: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-12 09:21:06

Significance of Nifty 50 Membership

As a prominent member of the Nifty 50 index, Sun Pharmaceutical Industries Ltd holds a strategic position within India’s benchmark equity gauge. Inclusion in this elite group not only enhances the stock’s visibility among domestic and global investors but also ensures consistent demand from index-tracking funds and institutional portfolios. This membership acts as a catalyst for liquidity and price stability, particularly during periods of market volatility.

The company’s large-cap status, with a market capitalisation of ₹4,49,251 crores, further cements its role as a cornerstone of the Pharmaceuticals & Biotechnology sector. Its weighting within the Nifty 50 reflects both its market val...

Read full news article

View All News